| Patents for C07J 13 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having a carbon-to-carbon double bond from or to position 17 (764) |
|---|
| 11/04/2004 | WO2004094450A1 Process for preparing guggulsterones and guggulsterol |
| 10/28/2004 | WO2004091474A2 Methods for the preparation of dhea derivatives |
| 09/23/2004 | US20040186306 Process for preparing Guggulsterones |
| 08/19/2004 | US20040162425 6,7-Oxygenated steroids and uses related thereto |
| 08/12/2004 | US20040157814 6, 7-Oxygenated steroids and uses related thereto |
| 08/10/2004 | CA2102400C Method for making 3.alpha.-hydroxy, 3.beta.-substituted-pregnanes |
| 07/22/2004 | WO2004060906A1 Process for preparing guggulsterones |
| 07/14/2004 | CN1157404C Novel fusidic acid derivatives |
| 07/13/2004 | CA2069248C Steroid derivatives of pregna-4,9(11),17(20)-trien-3-one, their preparation, their application to the preparation of steroidic compounds of pregna-4,9(11),16-trien-3,20 and novel intermediates-dione, |
| 06/02/2004 | EP1423407A1 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 06/02/2004 | CN1152045C Method for preparing 4,4-dimethyl-3 beta-hydroxypregna-8, 14-diene-21-carboxylic acid esters and the intermediate products obtained in said method |
| 04/21/2004 | EP1409513A1 Methylene-4-azasteroids |
| 04/21/2004 | EP1409512A1 20-fluoro-17(20)-vinyl steroids as inhibitors of c17-20-lyase and 5-alpha reductase |
| 04/06/2004 | US6717002 Reacting a 19- norsteroid derivative with an alcohol represented by roh and iodine in the absence of a rare earth compound catalyst |
| 03/16/2004 | US6706701 6, 7-oxygenated steroids and uses related thereto |
| 01/21/2004 | EP0914165A4 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety |
| 01/06/2004 | US6673783 Fusidic acid derivatives |
| 12/25/2003 | US20030236408 Estrogenic compounds as anti-mitotic agents |
| 11/25/2003 | US6653491 Method for producing 4,4-dimethyl-3β-hydroxypregna-8, 14-diene-21-carboxylic acid esters and intermediate products obtained by said method |
| 11/20/2003 | US20030216363 Method of treating hyperlipidemic and hyperglycemic conditions in mammals using pregnadienols and pregnadienones |
| 10/29/2003 | CN1452628A 4-halogenated 17-methylene steroids, method for production thereof and pharmaceutical compositions contg. these compounds |
| 10/28/2003 | CA2077625C Preparation process of hydrocortisone and novel intermediates |
| 09/24/2003 | CN1444597A 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity |
| 09/17/2003 | EP1343803A2 2-substituted estrogens as antiangiogenic agents |
| 07/15/2003 | US6593319 Fusidic acid derivatives |
| 06/17/2003 | US6579862 3B-hydroxy-pregna-5,16-dien-20-one |
| 06/17/2003 | US6579853 For inhibiting apoptosis or apoptosis-like cell death |
| 05/28/2003 | EP1232173B1 Fusidic acid derivatives |
| 05/22/2003 | US20030096800 Estrogenic compounds as anti-mitotic agents |
| 05/14/2003 | EP1310509A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 05/14/2003 | EP0830369B1 Nor-pregnanes for inducing hypothalamic effects |
| 04/23/2003 | EP1304333A2 6,7-Oxygenated steroids and uses related thereto |
| 04/16/2003 | EP0912185B1 Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs |
| 04/03/2003 | US20030064971 Fusidic acid derivatives |
| 03/20/2003 | US20030055029 Combbretastatin a-4 as an anti-angiogenic agent |
| 03/19/2003 | EP1056768B1 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 03/13/2003 | WO2003020744A1 Methylene-4-azasteroids |
| 03/13/2003 | WO2002042319A3 2-substituted estrogens as antiangiogenic agents |
| 03/05/2003 | EP1287017A1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity |
| 03/04/2003 | US6528676 Estrogenic compounds as anti-mitotic agents |
| 03/03/2003 | WO2002019971A1 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 12/26/2002 | US20020197286 Method for preventing and treating skin aging |
| 12/04/2002 | EP0917534B1 6,7-oxygenated steroids and uses related thereto |
| 11/20/2002 | CN1380063A Method for preventing and curing skid aging |
| 11/13/2002 | EP1163257B1 Method for producing 4,4-dimethyl-3beta-hydroxypregna-8,14-diene-21-carboxylic acid esters and intermediate products obtained by said method |
| 11/07/2002 | WO2002070537A3 Fusidic acid derivatives |
| 11/06/2002 | CN1378554A Novel fusidic acid derivatives |
| 10/03/2002 | US20020143199 Method of producing steroid derivatives |
| 10/03/2002 | US20020143001 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 09/24/2002 | US6455517 For therapy of conditions or diseases that are estrogen-dependent, i.e., are estrogen-induced or estrogen-stimulated |
| 09/12/2002 | WO2002070537A2 Fusidic acid derivatives |
| 09/11/2002 | EP1238590A1 Fat based food product |
| 09/10/2002 | CA2132449C 17 - substituted steroids useful in cancer treatment |
| 08/21/2002 | EP1232173A1 Fusidic acid derivatives |
| 08/20/2002 | US6437156 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
| 08/14/2002 | EP1230952A2 Combinations of estrogen and progestogen for preventing and treating skin aging |
| 08/13/2002 | US6432938 Nasal administering a steroid |
| 08/08/2002 | WO2002019971A9 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 08/07/2002 | EP1039912B1 Angiostatic agents and compositions for treating glc1a glaucoma |
| 08/01/2002 | US20020103391 17-methyleneandrost-4-en-3 alpha-ol for example; anxiolytic agents; ligand semiochemicals which bind to neuroepithelial receptors |
| 07/31/2002 | EP1226156A1 Process for producing phytosterols by saponification in an alcohol/water solvent |
| 07/23/2002 | US6423702 Process for the hydroxylation of an acyclic or cyclic methylene radical in the allylic position, pharmaceutical composition containing hydroxycholesterol derivatives and utilization of such compositions for the preparation of drugs |
| 07/16/2002 | CA2367186A1 Method for preventing and treating skin aging |
| 07/11/2002 | US20020091112 17-methylene steroids, process for their production and pharmaceutical compositions that contain these compounds |
| 07/02/2002 | US6413951 20-fluoro-17(20)-vinyl steroids |
| 05/30/2002 | WO2002042319A2 2-substituted estrogens as antiangiogenic agents |
| 05/30/2002 | CA2430100A1 Antiangiogenic agents |
| 04/10/2002 | CN1344272A Method for producing 4,4-dimethyl-3 beta-hydroxypregna-8, 14-diene-21-carboxylic acid esters and intermediate products obtained by said method |
| 04/04/2002 | DE10043846A1 17-Methylensteroide, Verfahren zu deren Herstellung und diese Verbindung enthaltende pharmazeutische Zusammensetzungen 17-methyl steroids, processes for their preparation and pharmaceutical compositions containing this compound |
| 03/14/2002 | US20020032181 For therapy of conditions or diseases that are estrogen-dependent, i.e., are estrogen-induced or estrogen-stimulated |
| 03/05/2002 | US6352980 Estrenes for inducting hypothalamic effects |
| 02/14/2002 | US20020019548 20-Fluoro-17(20)-vinyl steroids |
| 01/16/2002 | EP1172371A1 Process for the preparation of steroid derivatives |
| 01/16/2002 | CN1331698A Brain cell or nerve cell-protective agents comprising ginsenoside Rb1 |
| 01/03/2002 | WO2002000681A1 20-fluoro-17(20)-vinyl steroids as inhibitors of c17-20-lyase and 5-alpha reductase |
| 01/03/2002 | US20020002141 For inhibiting apoptosis or apoptosis-like cell death |
| 12/19/2001 | EP1163257A1 Method for producing 4,4-dimethyl-3beta-hydroxypregna-8,14-diene-21-carboxylic acid esters and intermediate products obtained by said method |
| 12/18/2001 | US6331534 Steroids as neurochemical stimulators of the VNO to alleviate pain |
| 12/05/2001 | EP1142903A9 BRAIN CELL OR NERVE CELL-PROTECTIVE AGENTS COMPRISING GINSENOSIDE Rb 1? |
| 11/15/2001 | WO2001085755A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity |
| 11/15/2001 | CA2408751A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity |
| 11/14/2001 | EP0686613B1 Ozonide reducing agent |
| 10/10/2001 | EP1142903A1 BRAIN CELL OR NERVE CELL-PROTECTIVE AGENTS COMPRISING GINSENOSIDE Rb 1? |
| 08/28/2001 | US6281205 Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 08/23/2001 | WO2001060836A1 Process for the preparation of steroid derivatives |
| 06/05/2001 | US6242619 19-norpregnane steroids as neurochemical initiators of change in human hypothalamic function |
| 05/10/2001 | WO2001032681A1 Process for producing phytosterols by saponification in an alcohol/water solvent |
| 04/26/2001 | WO2001029061A1 Novel fusidic acid derivatives |
| 04/11/2001 | CN1291196A Nevol anti-estrogenic steroids, and associated pharmaceutical compositions and method of use |
| 02/14/2001 | EP0815120B1 17-difluoromethylene-oestratrienes |
| 01/23/2001 | US6177418 Epoxidized and/or hydroxylated prostane derivatives derived from a fusidium coccineum fungus metabolite isolated from metabolite mixture of fusidic acid |
| 12/28/2000 | DE19911680A1 New extracts and compounds from Ganoderma pfeifferi , useful e.g. as antibacterial and antiviral agents, preservatives, cosmetic, pharmaceutical and food additives and in fish farming, are protease inhibitors |
| 12/06/2000 | EP1056768A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 10/31/2000 | US6140316 Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions |
| 10/25/2000 | CN1057767C Androstanes with inducing hypothalamic effects |
| 10/24/2000 | US6136800 Steroids |
| 10/11/2000 | CN1057303C Preparation process for 16 beta-methyl steroid and new intermediates thereof |
| 10/04/2000 | EP1039912A1 Angiostatic agents and compositions for controlling ocular hypertension |
| 09/28/2000 | WO2000056758A1 METHOD FOR PRODUCING 4,4-DIMETHYL-3β-HYDROXYPREGNA-8,14-DIENE-21-CARBOXYLIC ACID ESTERS AND INTERMEDIATE PRODUCTS OBTAINED BY SAID METHOD |
| 09/28/2000 | DE19914019C1 Verfahren zur Herstellung von 4,4-Dimethyl-3beta-hydroxypregna-8,14-dien-21-carbonsäureestern, deren Verwendung und Zwischenprodukte im Verfahren A process for the preparation of 4,4-dimethyl-3beta-hydroxypregna-8,14-diene-21-carboxylic acid esters, their use and intermediates in the process |